In line with a previous study showing a critical role of HIF1α in Sorafenib-naive cells [5], the results demonstrated that HIF1α was critically required for the maintenance of Sorafenib resistance in patient-derived HCC cell lines. The gene discussed is HIF1A; the disease is hepatocellular carcinoma.